- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
Recombinant p21 Antibody CIP1/4377R / CDKN1A Rabbit Monoclonal Antibody recognizes p21, a cyclin-dependent kinase inhibitor encoded by the CDKN1A gene. Also known as WAF1 and CIP1, p21 belongs to the CIP/KIP family of cell cycle regulators, which includes p27 (CDKN1B) and p57 (CDKN1C). The protein plays an important role in coordinating cell proliferation with DNA damage responses, differentiation signals, and cellular stress. Its activity is regulated through transcriptional mechanisms, protein interactions, post-translational modifications, and controlled degradation.
CDKN1A is a major transcriptional target of the tumor suppressor p53. Following DNA damage, p53 activation can increase p21 expression, leading to inhibition of cyclin-dependent kinase activity and cell cycle arrest. This response helps prevent the replication of damaged DNA while repair mechanisms operate. However, CDKN1A expression can also be induced independently of p53 through pathways involving transforming growth factor beta (TGF-beta), SP1 transcription factors, and other regulatory proteins. These mechanisms allow p21 to participate in cell cycle control under diverse physiological conditions.
At the molecular level, p21 binds cyclin E-CDK2 and cyclin A-CDK2 complexes, restricting their kinase activity and limiting progression through the G1/S transition. Its interactions with cyclin D-CDK4/6 complexes are more context-dependent, as p21 can contribute to complex assembly while also regulating kinase activity. Beyond cyclin-dependent kinase inhibition, p21 interacts with proliferating cell nuclear antigen (PCNA), linking its functions to DNA replication and repair. These interactions help coordinate cell cycle progression with the maintenance of genomic integrity.
The biological effects of p21 depend partly on its subcellular localization. Nuclear p21 is strongly associated with cell cycle inhibition, whereas cytoplasmic p21 can influence apoptosis-related signaling and cellular survival. Phosphorylation and other modifications affect its localization, stability, and interactions with regulatory proteins. Sustained p21 expression may contribute to cellular senescence, although its role varies with the nature of the initiating stress and the cellular environment.
CDKN1A is widely investigated in cancer biology because disruption of cell cycle checkpoints is a common feature of tumor development. Depending on cellular context, p21 can contribute to growth suppression or support survival under stressful conditions. NSJ Bioreagents offers this Recombinant p21 Antibody to support research into CDKN1A signaling, cell cycle checkpoints, cellular senescence, and mechanisms governing proliferation.
For additional research into CDKN1A-mediated cell cycle regulation and DNA damage responses, explore our p21 Antibody (V2431), featuring clone DCS-60.2.
Optimal dilution of the Recombinant p21 Antibody CIP1/4377R / CDKN1A Rabbit Monoclonal Antibody should be determined by the researcher.
A portion of amino acids 1-100 from the human protein was used as the immunogen for the Recombinant p21 Antibody CIP1/4377R.
Store the Recombinant p21 Antibody CIP1/4377R at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
CDKN1A antibody, Cyclin-Dependent Kinase Inhibitor 1A antibody, p21 CIP1 antibody, p21 WAF1 antibody
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.